Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Levomilnacipran Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurobindo's Generic Levomilnacipran Hydrochloride Receives Approval in the U.S.
    Aurobindo's Generic Levomilnacipran Hydrochloride Receives Approval in the U.S.

    06 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210826

    FDA
    06 Jan 2023
    Share Share
    Amneal Pharm's Generic Levomilnacipran Hydrochloride Receives Approval in US
    Amneal Pharm's Generic Levomilnacipran Hydrochloride Receives Approval in US

    04 Feb 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210790

    FDA
    04 Feb 2019
    Share Share
    US says Allergan's Units to Pay $38 Million to Settle Kickback Allegations
    US says Allergan's Units to Pay $38 Million to Settle Kickback Allegations

    16 Dec 2016

    // Susan Heavey REUTERS

    http://www.reuters.com/article/us-allergan-usa-forestlabs-idUSKBN1442BK

    Susan Heavey REUTERS
    16 Dec 2016
    Share Share
    Glenmark Pharmaceuticals settles patent litigation over anti-depressant drug
    Glenmark Pharmaceuticals settles patent litigation over anti-depressant drug

    21 Dec 2015

    // ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharmaceuticals-settles-patent-litigation-over-anti-depressant-drug/articleshow/50265123.cms

    ECONOMIC TIMES
    21 Dec 2015
    Share Share
    8 Invented Diseases Big Pharma Is Banking On
    8 Invented Diseases Big Pharma Is Banking On

    02 Feb 2015

    // Martha Rosenberg ALTERNET

    http://www.alternet.org/personal-health/8-invented-diseases-big-pharma-banking

    Martha Rosenberg ALTERNET
    02 Feb 2015
    Share Share